Sponsor or institution
Clinical trials and research at Guangzhou JOYO Pharma Co., Ltd
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Guangzhou JOYO Pharma Co., Ltd that are recruiting, in China. By phase: Phase 2 (2), Phase 1 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| JYP0015 for adults with advanced RAS‑mutant solid tumors | Phase 2 | Beijing, Beijing Municipality | Recruiting | Mar 26, 2025 |
| Evaluating JYP0061 for treating acute Neuromyelitis Optica Spectrum Disorders | Phase 2 | Changsha, Hunan | Recruiting | Nov 20, 2024 |
| Evaluating JYP0035 capsule for advanced solid tumors | Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Dec 6, 2023 |
| Testing JYP0322 for ROS1 Fusion-Positive Solid Tumors | Phase 1 | Guangzhou, Guangdong | Recruiting | Nov 13, 2023 |
| Evaluating Sufenidone for Idiopathic Pulmonary Fibrosis | Phase 2/3 | Beijing, Beijing Municipality | Recruiting | Nov 9, 2023 |
All recruiting trials (5)
-
JYP0015 for adults with advanced RAS‑mutant solid tumors
This trial tests whether the oral drug JYP0015 is safe and can shrink tumors in adults whose advanced solid cancers have specific RAS mutations.
-
Evaluating JYP0061 for treating acute Neuromyelitis Optica Spectrum Disorders
This study is testing a new treatment called JYP0061 to see if it can help people with acute Neuromyelitis Optica Spectrum Disorders feel better and stay safe while using it.
-
Evaluating JYP0035 capsule for advanced solid tumors
This study is testing a new capsule called JYP0035 to see if it's safe and how it works in people with advanced solid tumors.
-
Testing JYP0322 for ROS1 Fusion-Positive Solid Tumors
This study is testing a new oral medication called JYP0322 to see if it can help people with certain types of advanced solid tumors that have a specific genetic change called ROS1 fusion.
-
Evaluating Sufenidone for Idiopathic Pulmonary Fibrosis
This study is testing a new medication called Sufenidone to see if it can help people with Idiopathic Pulmonary Fibrosis breathe better and stay healthier compared to a placebo.
Quick answers
How many clinical trials run by Guangzhou JOYO Pharma Co., Ltd are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.